Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Abstract Background Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an individual randomized controlled trial (RCT) is underpowered to determine whe...
Enregistré dans:
Auteurs principaux: | Noppacharn Uaprasert, Krissana Panrong, Ponlapat Rojnuckarin, Thita Chiasakul |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/60d90bd8c2444aebb5c495d3a2b9c9c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
par: Qiyan Cai, et autres
Publié: (2021) -
Heritable Thrombophilia in Venous Thromboembolism in Northern Pakistan: A Cross-Sectional Study
par: Maria Khan, et autres
Publié: (2021) -
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
par: Masarret Fazili, et autres
Publié: (2020) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
par: Victoria Speed, et autres
Publié: (2021) -
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
par: Elrazi Ali, et autres
Publié: (2021)